In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Novartis exercises put option for GSK to buy rest of consumer health JV for $13bn

Executive Summary

GlaxoSmithKline PLC paid $13bn to acquire the 36.5% ownership stake held by Novartis AG in their consumer health joint venture.
Deal Industry
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Divestiture/Spin-Out
    • Payment Includes Cash
    • Partial Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register